These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1758538)

  • 1. Hyperlactataemia and metabolic acidosis during haemofiltration using lactate-buffered fluids.
    Davenport A; Will EJ; Davison AM
    Nephron; 1991; 59(3):461-5. PubMed ID: 1758538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of lactate-buffered solutions on the acid-base status of patients with renal failure.
    Davenport A; Will EJ; Davison AM
    Nephrol Dial Transplant; 1989; 4(9):800-4. PubMed ID: 2516612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactate and acid base changes in the critically ill.
    Nimmo GR; Grant IS; Mackenzie SJ
    Postgrad Med J; 1991; 67 Suppl 1():S56-61. PubMed ID: 1924080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which bicarbonate concentration is adequate to lactate-buffered substitution fluids in maintenance hemofiltration?
    Böhm R; Gladziwa U; Clasen W; Riehl J; Mann H; Sieberth HG
    Clin Nephrol; 1994 Oct; 42(4):257-62. PubMed ID: 7834919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bicarbonate-based haemofiltration in the management of acute renal failure with lactic acidosis.
    Hilton PJ; Taylor J; Forni LG; Treacher DF
    QJM; 1998 Apr; 91(4):279-83. PubMed ID: 9666950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acid-base effects of continuous hemofiltration with lactate or bicarbonate buffered replacement fluids.
    Tan HK; Uchino S; Bellomo R
    Int J Artif Organs; 2003 Jun; 26(6):477-83. PubMed ID: 12866653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperlactataemia and increasing metabolic acidosis due to the use of lactate based fluid during haemofiltration.
    Davenport A; Aulton K; Payne RB; Will EJ
    Intensive Care Med; 1989; 15(8):546-7. PubMed ID: 2607050
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure.
    Heering P; Ivens K; Thümer O; Morgera S; Heintzen M; Passlick-Deetjen J; Willers R; Strauer BE; Grabensee B
    Intensive Care Med; 1999 Nov; 25(11):1244-51. PubMed ID: 10654208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid-base responses to high-volume haemofiltration in the critically ill.
    Nimmo GR; Mackenzie SJ; Walker S; Nicol M; Grant IS
    Nephrol Dial Transplant; 1993; 8(9):854-7. PubMed ID: 8255519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction.
    McLean AG; Davenport A; Cox D; Sweny P
    Kidney Int; 2000 Oct; 58(4):1765-72. PubMed ID: 11012911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of a lactate-versus acetate-based hemofiltration replacement fluid in patients with acute renal failure.
    Morgera S; Heering P; Szentandrasi T; Manassa E; Heintzen M; Willers R; Passlick-Deetjen J; Grabensee B
    Ren Fail; 1997 Jan; 19(1):155-64. PubMed ID: 9044462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperlactatemia and increasing metabolic acidosis in hepatorenal failure treated by hemofiltration.
    Davenport A; Aulton K; Payne RB; Will EJ
    Ren Fail; 1990; 12(2):99-101. PubMed ID: 2236733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactate or bicarbonate for intermittent hemofiltration?
    Clasen M; Böhm R; Riehl J; Gladziwa U; Dakshinamurty KV; Schacht B; Mann H; Sieberth HG
    Contrib Nephrol; 1991; 93():152-5. PubMed ID: 1802569
    [No Abstract]   [Full Text] [Related]  

  • 14. Paradoxical increase in arterial hydrogen ion concentration in patients with hepatorenal failure given lactate-based fluids.
    Davenport A; Will EJ; Davison AM
    Nephrol Dial Transplant; 1990; 5(5):342-6. PubMed ID: 2115625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of lactate and bicarbonate buffered haemofiltration fluids: use in critically ill patients.
    Thomas AN; Guy JM; Kishen R; Geraghty IF; Bowles BJ; Vadgama P
    Nephrol Dial Transplant; 1997 Jun; 12(6):1212-7. PubMed ID: 9198053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients.
    Barenbrock M; Hausberg M; Matzkies F; de la Motte S; Schaefer RM
    Kidney Int; 2000 Oct; 58(4):1751-7. PubMed ID: 11012909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insufficient correction of blood bicarbonate levels in biguanide lactic acidosis treated with CVVH and bicarbonate replacement fluids].
    Mariano F; Goia F; Vincenti R; Capra L; Lanza G; Curto V; Cavalli PL
    Minerva Urol Nefrol; 1997 Sep; 49(3):133-6. PubMed ID: 9432735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy.
    Vecchio S; Giampreti A; Petrolini VM; Lonati D; Protti A; Papa P; Rognoni C; Valli A; Rocchi L; Rolandi L; Manzo L; Locatelli CA
    Clin Toxicol (Phila); 2014 Feb; 52(2):129-35. PubMed ID: 24283301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of continuous haemofiltration to assess the rate of lactate metabolism in acute renal failure.
    Wright DA; Forni LG; Carr P; Treacher DF; Hilton PJ
    Clin Sci (Lond); 1996 Jun; 90(6):507-10. PubMed ID: 8697721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactate- or bicarbonate-buffered solutions in continuous extracorporeal renal replacement therapies.
    Kierdorf HP; Leue C; Arns S
    Kidney Int Suppl; 1999 Nov; (72):S32-6. PubMed ID: 10560802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.